MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.400
+0.030 (2.19%)
At close: Jun 6, 2025, 4:00 PM
1.360
-0.040 (-2.86%)
After-hours: Jun 6, 2025, 5:36 PM EDT

MIRA Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-7.92-7.85-11.98-7.06-2.18-0.2
Stock-Based Compensation
2.31.922.551.3--
Other Operating Activities
--5.540.010.02-
Change in Accounts Payable
-0.530.18-0.390.150.78-
Change in Other Net Operating Assets
0.010.19-0.25-0.01--
Operating Cash Flow
-6.14-5.56-4.53-5.6-1.38-0.2
Short-Term Debt Issued
--2.15-0.2-
Total Debt Issued
--2.15-0.20.27
Short-Term Debt Repaid
---1.14-0.16--
Total Debt Repaid
0.02--1.14-0.16--
Net Debt Issued (Repaid)
0.02-1.01-0.160.20.27
Issuance of Common Stock
3.613.617.72.94.51-
Other Financing Activities
0.180.180.070.4-0.53-0.06
Financing Cash Flow
3.823.798.783.154.180.21
Net Cash Flow
-2.32-1.774.25-2.462.810.01
Levered Free Cash Flow
-3.26-2.72-5.46-3-0.66-
Unlevered Free Cash Flow
-3.26-2.72-3.3-2.99-0.64-
Change in Net Working Capital
0.52-0.370.52-0.12-0.7-
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q